Natera
Natera is seeking a Senior Director to lead the research, development, and clinical translation of AI and computational algorithms for oncology diagnostics. This role involves shaping the foundation model strategy, building and leading an algorithm team, and partnering with cross-functional leaders to prioritize clinical use cases and drive product deployment. The position requires a scientific leader with a compelling vision for advancing oncology diagnostics through multimodal AI products.
Headquarters
Austin, Texas, United States
Company Size
1001-5000 employees
Founded
2004
Natera is a molecular diagnostics company that develops and commercializes cell-free DNA testing for oncology, women's health, organ health, and rare disease. Its tests are used for cancer detection and monitoring, noninvasive prenatal and carrier screening, transplant rejection assessment, and genomic analysis for rare diseases. Natera's clinically validated tests are processed in CAP/CLIA-certified labs and supported by over 400 peer-reviewed publications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Natera.
Natera's 1.18% Stock Decline Despite $280M Volume Surge Ranks 429th in Trading Activity
14 hours ago
Senior Scientist, AI for Oncology Clinical Development
AstraZeneca
Senior Director MMAI & Outcome Prediction – AI for Precision Health
AstraZeneca
AI Scientist/Senior, Clinical & Molecular Genomics Modeling, BRAID
Genentech
Research Scholar, Biostatistics Service
Memorial Sloan Kettering Cancer Center
Senior Multimodal Ai Scientist %E2%80%93 Computational Radiology Boston Massachusetts United States Of America
AstraZeneca
Senior Multimodal AI Scientist – Computational Radiology
AstraZeneca